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miR-124 dosage regulates 
prefrontal cortex function by 
dopaminergic modulation
takashi Kozuka1,2, Yoshihiro omori  1,2, Satoshi Watanabe1,2, Etsuko tarusawa3, 
Haruka Yamamoto1, Taro Chaya1,2, Mayu Furuhashi1, Makiko Morita4, Tetsuya sato5, 
shinichi Hirose7, Yasuyuki ohkawa  6, Yumiko Yoshimura3, Takatoshi Hikida4,8 & 
takahisa Furukawa1,2
MicroRNA-124 (miR-124) is evolutionarily highly conserved among species and one of the most 
abundantly expressed miRNAs in the developing and mature central nervous system (CNs). previous 
studies reported that miR-124 plays a role in CNS development, such as neuronal differentiation, 
maturation, and survival. However, the role of miR-124 in normal brain function has not yet been 
revealed. Here, we subjected miR-124-1+/− mice, to a comprehensive behavioral battery. We found 
that miR-124-1+/− mice showed impaired prepulse inhibition (PPI), methamphetamine-induced 
hyperactivity, and social deficits. Whole cell recordings using prefrontal cortex (PFC) slices showed 
enhanced synaptic transmission in layer 5 pyramidal cells in the miR-124-1+/− pFC. Based on the results 
of behavioral and electrophysiological analysis, we focused on genes involved in the dopaminergic 
system and identified a significant increase of Drd2 expression level in the miR-124-1+/− pFC. 
overexpression or knockdown of Drd2 in the control or miR-124-1+/− pFC demonstrates that aberrant 
Drd2 signaling leads to impaired PPI. Furthermore, we identified that expression of glucocorticoid 
receptor gene Nr3c1, which enhances Drd2 expression, increased in the miR-124-1+/− pFC. taken 
together, the current study suggests that miR-124 dosage modulates pFC function through repressing 
the Drd2 pathway, suggesting a critical role of miR-124 in normal pFC function.
MicroRNAs (miRNAs) are small non-coding RNA molecules regulating gene expression of a great variety of 
biological processes in plants and animals. A large number of diverse miRNAs are expressed in the vertebrate 
CNS. MicroRNA-124 (miR-124) is one of the most abundantly expressed miRNAs in mouse and human brains1. 
The nucleotide sequence of miR-124 and its nervous system-specific expression pattern are highly evolutionar-
ily conserved from C. elegans through Drosophila melanogaster, and all vertebrates studied through to humans. 
Both in human and mouse genomes, miR-124s are encoded on three loci: miR-124-1, -2, and -3. Among the 
three primary miR-124s (pri-miR-124s), pri-miR-124-1 is predominantly expressed2. In mice, retinal non-coding 
RNA3 (RNCR3) functions as a pri-miR-124-1 precursor. We previously identified RNCR3 in the mouse retina 
and generated RNCR3-deficient mice (RNCR3−/−) by deleting the entire 4.5 kb region harboring RNCR32. In 
the RNCR3−/− brain, the level of mature miR-124 was reduced by 60–80% compared with that in the wild-type 
(WT) brain. RNCR3−/− mice showed abnormalities in the CNS such as over-extension of dentate gyrus granule 
neuron axons and apoptosis of cone photoreceptor cells in the retina2. Since in our previous study we confirmed 
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that a loss of miR-124 is responsible for the RNCR3−/− abnormalities by in vivo rescue experiment, we will refer to 
RNCR3−/− mice as miR-124-1−/− mice in the current study.
In C. elegans miR-124 mutants, neurons are normally generated and no overt phenotype was observed3,4. 
Drosophila miR-124 mutants exhibit abnormalities in neuroblast proliferation and neuronal maturation5,6. In 
vertebrates, consistent with its expression pattern in the developing CNS, miR-124 has been reported to be essen-
tial for neuronal differentiation7,8, maturation2,9–11, synaptic plasticity12,13 and progenitor proliferation7, however, 
it should be noted that conflicting results on miR-124 function have been reported. It was reported that neither 
inhibition nor overexpression of miR-124 affected neuronal differentiation or progenitor proliferation in the 
chick neural tube9. On the other hand, other studies reported that miR-124 promotes both embryonic and adult 
neurogenesis7,14. In the chick spinal cord, miR-124 was implicated in the stimulation of neuronal differentiation 
through suppressing the anti-neuronal REST/SCP1 pathway. In addition, miR-124 induces neurogenesis in P19 
mouse embryonic cells7. In the adult mouse subventricular zone, miR-124 was shown to induce adult neurogen-
esis through regulation of Sox914.
Human miR-124-1 is located in the chromosome 8p23.1 region. Heterozygous deletions on human 8p23.1 have 
been reported to be associated with psychiatric disorders, including schizophrenia, autism, and social impair-
ment15–18. Due to its location on 8p23.119 and because of its specific expression to the CNS, human miR-124-1 
is implicated to be associated with mental diseases.
Despite of many studies, the role of miR-124 in normal brain function remains unclarified. While miR-124-1−/− 
mice show aberrant growth of dentate granule cell axons in the hippocampus2, miR-124-1+/− mice exhibited no 
substantial morphological defects in the brain development as far as we analyzed. In the current study, we inves-
tigated the role and mechanism of miR-124 in normal brain functions using miR-124-1+/− mice.
Results
A comprehensive behavioral test battery for miR-124-1+/− mice. To address whether miR-124-1 
haploinsufficiency affects normal brain functions, we subjected miR-124-1+/− mice to a comprehensive behavioral 
test battery. In the rotarod test, miR-124-1+/− mice exhibited normal motor function (Fig. 1a; two-way repeated- 
measures ANOVA: Genotype: F(1, 12) = 0.001206, p = 0.9729; Time: F(8, 96) = 19.94, p < 0.0001; Interaction: F(8, 96) = 
0.1703, p = 0.9943). We monitored locomotor activity of the miR-124-1+/− mice in the open field test, and observed 
no significant difference in total distance traveled compared with WT control mice (Fig. 1b; two-way repeat-
ed-measures ANOVA: Genotype: F(1, 12) = 0.02964, p = 0.8662; Time: F(11, 132) = 18.44, p < 0.0001; Interaction: 
F(11, 132) = 0.9734, p = 0.4738). To assess anxiety-like behavior, we monitored time spent in the central part of 
the open field. We also measured the number of entries to the open arm and cumulative time spent in the open 
arm of the elevated plus maze. There were no significant differences in these parameters between miR-124-1+/− 
and WT mice (Fig. 1c–g; unpaired t test: t(12) = 1.029, p = 0.3236; unpaired t test: t(19) = 1.752, p = 0.0959; unpaired 
t test: t(19) = 1.676, p = 0.1101; unpaired t test: t(19) = 1.219, p = 0.2377; unpaired t test: t(19) = 0.9325, p = 0.3628). 
To test whether miR-124-1 haploinsufficiency contributes to depression-like behavior, we subjected miR-124-1+/− 
mice to tail suspension and forced swim tests. miR-124-1+/− mice exhibited no significant difference in immobil-
ity time (Fig. 1h,i; unpaired t test: t(10) = 0.3745, p = 0.7518; unpaired t test: t(10) = 0.3952, p = 0.7010). To test for 
short-term memory deficit, we conducted a test of spontaneous Y-maze alternations, a spatial working memory 
task based on the natural tendency of mice to alternate the selection of maze arms. We did not observe differences 
in spontaneous alternation between miR-124-1+/− and WT mice (Fig. 1j; unpaired t test: t(18) = 0.00, p > 0.9999). 
These results suggest that miR-124-1 haploinsufficiency does not affect normal motor function, anxiety-like 
behavior, depression-like behavior, or spatial working memory. The previous study shows that miR-124-1−/−  
mice exhibit a significantly decreased number of cone photoreceptor cells and an impairment of photopic elec-
troretinogram (ERG) responses2. We measured the ERG responses from miR-124-1+/− mice and observed no 
substantial ERG abnormalities (Supplementary Material Fig. S1a–c). We also analyzed cone photoreceptor integ-
rity in the miR-124-1+/− retina by immunofluorescent staining and observed no significant differences between 
miR-124-1+/− and control retinas (Supplementary Material Fig. S1d). These results suggest that miR-124-1+/− 
mice have no substantial defects in the retina.
Haploinsufficiency of miR-124-1 causes abnormalities in social, psychostimulant induced 
behaviors, and sensorimotor gating. Since social deficits often appear in psychiatric disorders20, we 
examined the sociability of miR-124-1+/− mice by social interaction test. Although there was no significant dif-
ference in the total duration of contacts between miR-124-1+/− and WT control mice, the total number of con-
tacts for miR-124-1+/− mice decreased significantly compared to that of WT mice (Fig. 2a,b; unpaired t test: 
t(14) = 0.8695, p = 0.3993; unpaired t test: t(14) = 2.980, p = 0.0099). In addition, although the spontaneous loco-
motor activity in miR-124-1+/− mice was unchanged in the open field test (Fig. 1b), the total distance traveled 
in social interaction was significantly decreased (Fig. 2c; unpaired t test: t(14) = 3.791, p = 0.0020). These results 
suggest that miR-124-1 haploinsufficiency causes social behavior deficits.
A dopaminergic psychostimulant, methamphetamine, raises dopamine levels in the nucleus accum-
bens and frontal cortex, and increases locomotor activity21. To examine whether miR-124-1+/− mice show 
dopamine-associated behavioral deficits, we investigated the response of miR-124-1+/− mice to methamphet-
amine using the open field. We found that the distance traveled by miR-124-1+/− mice in the open field test 
increased significantly compared to WT mice after methamphetamine administration (Fig. 2d; two-way 
repeated-measures ANOVA: Genotype: F(1, 13) = 6.714, p = 0.0224; Time: F(12, 156) = 4.304, p < 0.0001; Interaction: 
F(12, 156) = 6.334, p < 0.0001). This result suggests that miR-124-1 haploinsufficiency affects dopamine signaling 
associated with psychostimulant-induced hyperactivity.
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Prepulse inhibition (PPI) is a reduction in an acoustic startle response observed when a weak stimulus (pre-
pulse) is presented before the startling stimulus22. PPI is a measure of sensorimotor gating that is impaired in 
various neuropsychiatric disorders, including schizophrenia, Huntington’s disease, Tourette’s disease23, autism24, 
and panic disorder25. To test whether miR-124-1 haploinsufficiency affects sensorimotor gating, we measured PPI 
in miR-124-1+/− mice. We observed that the amplitudes of acoustic startle response were similar in miR-124-1+/− 
and WT mice (Fig. 2e; unpaired t test: t(16) = 2.046, p = 0.0576). In contrast, we found that the percentages of 
PPI both with 78 dB and 86 dB prepulses decreased significantly in miR-124-1+/− mice (Fig. 2f; unpaired t test: 
t(16) = 2.566, p = 0.0207; unpaired t test: t(16) = 2.745, p = 0.0144), suggesting that miR-124-1 haploinsufficiency 
results in a deficit of sensorimotor gating in mice.
Figure 1. A comprehensive behavioral test battery for miR-124-1+/− mice. (a) Rotarod test of miR-124-1+/− mice 
for analysis of motor function integrity (WT, n = 9; Het n = 5). Latency to fall was measured. (b,c) In open field, 
locomotor activity and anxiety-like behavior of WT control and miR-124-1+/− mice were measured based on the 
distance traveled and time in center (WT, n = 9; Het, n = 5). (d–g) Elevated plus maze test of miR-124-1+/− mice 
for analyzing the anxiety-like behavior. A cumulative time spent in the open arm, a number of entries to the open 
arm, total entries, and total distance moved were monitored (WT, n = 13; Het, n = 8). (h) Tail suspension test of 
miR-124-1+/− mice for analysis of depression-like behavior. Immobility time was measured (n = 6 per genotype). 
(i) Forced swim test of miR-124-1+/− mice for analysis of depression-like behavior. Immobility time was measured 
(n = 6 per genotype). (j) Y-maze test of miR-124-1+/− mice for a spatial working memory task based on the natural 
tendency of mice to alternate the selection of maze arms. Percentages of spontaneous alternation was measured 
(n = 10 per genotype). Error bars represent ± SD.
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Partial rescue of the PPI deficit in miR-124-1+/− mice. We observed multiple types of behavior deficits 
in miR-124-1+/− mice: social deficits, methamphetamine-induced hyperactivity, and impairment of PPI. Since all 
of these phenotypes are associated with the impairment of prefrontal cortex (PFC) functioning26–28, we focused 
on the role of miR-124-1 in the PFC. First, we examined expression of miR-124 in the PFC from miR-124-1+/− and 
WT control mice at 1-month old (M) and 2 M by qRT-PCR analysis, and found that the miR-124 levels signifi-
cantly decreased in the miR-124-1+/− PFC compared with those in the WT PFC at both stages (Supplementary 
Material Fig. S1e,f). To determine whether downregulation of miR-124 contributes to the impairment of PFC 
function in miR-124-1+/− mice, we tested whether the impaired PPI in miR-124-1+/− mice can be rescued by over-
expression of miR-124 in the PFC. We prepared an adeno-associated virus (AAV) expressing DsRed and miR-124 
(AAV-DsRed-miR-124) (Fig. 2g). We injected AAV-DsRed-miR-124 or control AAV-DsRed into the PFC of 2 M 
WT and miR-124-1+/− mice, and measured PPI at 2 weeks (wks) after AAV injection. We confirmed that injection 
of AAV-DsRed-miR-124 significantly increases the expression level of miR-124 in the PFC of miR-124-1+/− mice 
(Fig. 2h; Mann–Whitney U test: p = 0.0061). Injection of AAV-DsRed-miR-124 or control AAV-DsRed into the 
PFC of WT mice did not affect the amplitudes of the acoustic startle response or PPI (Fig. 2i; two-way ANOVA: 
Genotype: F(1, 49) = 2.301, p = 0.1357; Virus: F(1, 49) = 7.740, p = 0.0076; Interaction: F(1, 49) = 0.7856, p = 0.3798). 
In contrast, the impaired PPI with an 86 dB prepulse in miR-124-1+/− mice recovered with the injection of 
AAV-DsRed-miR-124 (Fig. 2j; two-way ANOVA: Genotype: F(1, 49) = 1.161, p = 0.2865; Virus: F(1, 49) = 0.4301, 
Figure 2. miR-124-1 haploinsufficiency results in behavioral deficits. (a–c) Sociability of miR-124-1+/− mice 
was measured based on interaction duration (a), the number of contacts (b) (n = 8 per genotype; **p < 0.01), 
and total distance traveled during social interaction (c) (n = 8 per genotype; **p < 0.01). (d) Methamphetamine 
induced hyperactivity in miR-124-1+/− mice but not in WT control mice (WT, n = 10; Het, n = 5). (e,f) PPI in 
miR-124-1+/− mice was impaired, whereas startle response amplitude was not significantly changed compared 
with that in WT mice (WT, n = 11; Het, n = 7; *p < 0.05, **p < 0.01; n.s., not significant). (g) A schematic of the 
AAV construct expressing miR-124 and Ds-Red (AAV-DsRed-miR-124). AAV-DsRed-miR-124 was injected 
into the PFC of 2 M WT and miR-124-1+/− mice. Fluorescence indicates the brain section injected with AAV-
DsRed-miR-124. L, lateral; M, medial; D, dorsal; V, ventral; PL, prelimbic; IL, infralimbic. (h) Quantification of 
miR-124 expression level in the PFC of AAV-DsRed-miR-124-injected miR-124-1+/− mice (control AAV-DsRed 
injected, n = 7; AAV-DsRed-miR-124 injected, n = 4; **p < 0.01). The dotted line indicates miR-124 expression 
level in control AAV-DsRed-injected WT mice. (i,j) Injection of AAV-DsRed-miR-124 into the PFC rescued the 
PPI deficit in miR-124-1+/− mice (n = 12-15 per group; *p < 0.05, **p < 0.01). Error bars in (a–d) represent ± SD. 
Box–whisker plots present median (center line), ±1.5 interquartile range (box), minimal and maximal values 
(whiskers) in (e,f,h–j).
5Scientific RepoRts |          (2019) 9:3445  | https://doi.org/10.1038/s41598-019-38910-2
www.nature.com/scientificreportswww.nature.com/scientificreports/
Figure 3. The effect of miR-124-1 haploinsufficiency on synaptic transmissions in layer 5 pyramidal cells 
in the PFC. (a) A schematic representing the recording region (red square) in PFC slices. PL, prelimbic, IL, 
infralimbic. (b) IR-DIC image of the PL region and the location of stimulating and recording electrodes. (c) 
Representative images showing biocytin-filled layer 5 pyramidal cells in WT control (left) and miR-124-1+/− 
mice (right). (d) Example average (n = 20) traces of EPSCs (left) and IPSCs (right) evoked by paired-pulse 
electrical stimulation at three stimulus intensities in WT (upper, black) and miR-124-1+/− mice (lower, red).  
(e) The average peak amplitude of evoked EPSCs (left) and IPSCs (right) was plotted against the stimulus 
intensity. Vertical and horizontal error bars indicate the SEM of the amplitude of evoked responses and the 
intensity of stimulation, respectively (n = 11 per genotype; *p < 0.05). (f) Paired-pulse ratio (PPR) of EPSCs 
(left) and IPSCs (right), respectively (WT, n = 9; Het = 11). (g) Example average (n = 20) traces of EPSCs 
before (pre, lighter color) and during (darker color) quinpirole application in WT (upper, black) and miR-124-
1+/− (lower, red) mice. (h) Plots of the peak amplitude of EPSCs before (pre) and during quinpirole application 
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p = 0.5150; Interaction: F(1, 49) = 0.2737, p = 0.6032; two-way ANOVA: Genotype: F(1, 49) = 7.184, p = 0.0100; Virus: 
F(1, 49) = 2.768, p = 0.1025; Interaction: F(1, 49) = 5.393, p = 0.0244). These results suggest that the expression level of 
miR-124 in the PFC is critical for normal sensorimotor gating in mice.
miR-124-1 haploinsufficiency enhances synaptic transmission in layer 5 pyramidal cells in the PFC. 
To investigate the effect of miR-124-1 haploinsufficiency on synaptic transmission in the PFC, we conducted 
whole-cell recordings from layer 5 pyramidal neurons in PFC slices prepared from miR-124-1+/− mice (Fig. 3a–c). 
To make a comparison of the strength of excitatory and inhibitory synaptic inputs to the pyramidal cells between 
the WT control and miR-124-1+/− mice, we recorded excitatory postsynaptic currents (EPSCs) at −70 mV and 
inhibitory postsynaptic currents (IPSCs) at 0 mV in response to electrical stimulation of presynaptic fibers at 
three different intensities (Fig. 3d). The slopes of the stimulus-response curves for EPSCs and IPSCs were both 
significantly steeper in miR-124-1+/−, compared with WT mice (Fig. 3e; unpaired t test: t(19) = 2.301, p = 0.0329; 
unpaired t test: t(20) = 2.611, p = 0.0167). There were no significant differences in the paired-pulse ratio of EPSCs 
or IPSCs between WT and miR-124-1+/− mice (Fig. 3f; unpaired t test: t(18) = 0.08295, p = 0.9348; unpaired t test: 
t(20) = 0.7042, p = 0.4894). These results suggest that both excitatory and inhibitory synaptic transmissions in layer 
5 pyramidal neurons are enhanced by miR-124-1 heterozygous deficiency.
We observed hypersensitivity of locomotor activity induced by methamphetamine administration and 
impaired PPI in miR-124-1+/− mice (Fig. 2d,f). Previous studies have reported that absence of Dopamine D2 
receptor (Drd2) attenuates the disruption of PPI induced by amphetamine29, and methamphetamine-induced 
hyperactivity30. To investigate whether dopamine regulation of local circuit processing in the PFC is affected in 
miR-124-1+/− mice, we examined the effects of Drd2 activation on synaptic transmission in miR-124-1+/− mice. 
We observed a significant reduction in EPSC amplitude after the application of 5 μM quinpirole, a Drd2 agonist, 
in both miR-124-1+/− mice and WT mice, but no significant difference in the level of reduction between them 
(Fig. 3g–i; paired t test: t(9) = 3.165, p = 0.0115; paired t test: t(9) = 5.436, p = 0.0004; unpaired t test: t(18) = 0.6279, 
p = 0.5379). On the other hand, the amplitude of IPSCs significantly decreased by quinpirole application in miR-
124-1+/− mice but not in WT mice (Fig. 3j–l; paired t test: t(10) = 2.054, p = 0.0670; paired t test: t(10) = 6.770, 
p < 0.0001; unpaired t test: t(20) = 2.213, p = 0.0387). These results suggest that Drd2-mediated dopaminergic 
modulatory effects on inhibitory transmissions increased in the pyramidal cells in the PFC of miR-124-1+/− mice. 
We speculated that PPI deficit and methamphetamine-induced hyperactivity observed in miR-124-1+/− mice are 
likely due to modulation of the dopaminergic system by miR-124 reduction in the PFC.
Drd2 is up-regulated in the miR-124-1+/− pFC. To explore the molecular mechanism of behavioral defi-
cits observed in miR-124-1+/− mice, we focused on genes involved in the dopaminergic system. We searched for 
miR-124 target sites in 3′UTR of dopamine-related genes, including dopamine receptor genes (Drd1-5), a dopa-
mine transporter gene (DAT), a dopamine synthesis gene (TH), and a dopamine metabolism gene (MAOB), and 
found that only the 3′UTR of Drd2 possesses an evolutionally conserved miR-124 target sequence (Fig. 4a). We 
observed that total Drd2 (containing both long and short variants) increased in 2 M miR-124-1+/− PFC (Fig. 4b; 
unpaired t test: t(11) = 2.749, p = 0.0189).
To examine the targeting effect of miR-124 on the Drd2-3′UTR, we performed a luciferase reporter assay. We 
prepared reporter plasmids containing native Drd2-3′UTR (Drd2-3′UTR) and Drd2-3′UTR with mutations in 
the miR-124 target site (Drd2-3′UTRmut) (Fig. 4c). We observed that luciferase activity shows no obvious change 
between the cells transfected with Drd2-3′UTR and those transfected with Drd2-3′UTRmut (one-way ANOVA: 
F(3, 8) = 4.156, p = 0.0476). This result suggests that Drd2 is not a direct target of miR-124, but is indirectly regu-
lated by miR-124 in the PFC.
expression level of Drd2 in the PFC affects PPI. To test whether Drd2 suppression in the miR-124-1+/− 
PFC rescues the PPI, we used AAVs expressing shDrd2 to knockdown Drd2 (AAV-shDrd2) or a control shRNA 
(AAV-shControl)31 (Fig. 4d). We injected AAV-shDrd2 into the miR-124-1+/− PFC at 2 M and measured PPI at 2 
wks after injection. Acoustic startle amplitude was unchanged between AAV-shControl- or AAV-shDrd2-injected 
mice (Fig. 4e; Mann–Whitney U test: p = 0.9336). No significant change of PPI with a 78 dB prepulse was 
observed in these mice, in contrast, a significant recovery of the PPI deficit was observed by knockdown of Drd2 
in the PFC with an 86 dB prepulse (Fig. 4f; Mann–Whitney U test: p = 0.1650; Mann–Whitney U test: p = 0.0274). 
These results suggest that the impaired PPI in miR-124-1+/− mice is at least partially caused by Drd2 increase in 
the PFC.
To investigate whether Drd2 overexpression in the PFC affects PPI, we prepared AAVs expressing Drd2 
(AAV-Drd2) or EGFP (AAV-GFP), and co-injected them into the PFC of WT mice at 2 M (Fig. 4g). We observed 
no significant change of startle amplitude between control AAV-GFP- and AAV-Drd2-injected mice (Fig. 4h; 
Mann–Whitney U test: p = 0.2890). No significant change of PPI with a 78 dB prepulse was observed in these 
mice, however, we observed a significant PPI decrease with an 86 dB prepulse in mice with Drd2 overexpression 
in WT (black, left) and miR-124-1+/− (red, right) mice (n = 10 per genotype; *p < 0.05, ***p < 0.001). (i) The 
ratio of EPSC amplitude before and during quinpirole application in WT (black, left) and miR-124-1+/− (red, 
right) mice. (j) Example average (n = 20) traces of IPSCs before (pre, lighter color) and during (darker color) 
quinpirole application in WT (upper, black) and miR-124-1+/− (lower, red) mice. (k) Plots of the peak amplitude 
of IPSCs before (pre) and during quinpirole application in WT (black, left) and miR-124-1+/− (red, right) mice 
(n = 11 per genotype; ****p < 0.0001; n.s., not significant). (l) The ratio of IPSC amplitude before and during 
quinpirole application in WT (black, left) and miR-124-1+/− (red, right) mice (*p < 0.05).
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by AAV-Drd2 injection into the PFC (Fig. 4i; Mann–Whitney U test: p = 0.1375; Mann–Whitney U test: 
p = 0.0350). These results suggest that Drd2 level change is at least partially responsible for the sensorimotor 
gating abnormality in the PFC of miR-124-1+/− mice.
In the reporter assay, we did not observe a significant change in luciferase activity between native and mutated 
Drd2-3′UTR constructs (Fig. 4c). How was Drd2 expression enhanced in the miR-124-1+/− PFC? To address this 
question, we further screened miR-124 target genes in the PFC. To identify miR-124 target genes in the PFC, we 
performed high-throughput mRNA sequencing (RNA-seq) analysis using RNAs isolated from miR-124-1+/− PFC 
or control PFC at 2 M (Fig. 5a). We identified 3,480 upregulated genes (more than 1.1-fold increase) in the miR-
124-1+/− PFC. We next searched for putative target genes of miR-124 in the context of PFC development. We 
Figure 4. Effect of Drd2 expression level in the PFC to PPI deficit. (a) Drd2 3′UTR contains a miR-124 target 
site. A miR-124 target site in Drd2 3′UTR was predicted by TragetScan. This target site is conserved among 
several mammalian species. (b) Drd2 expression level in the miR-124-1+/− PFC is quantified by qRT-PCR 
(WT, n = 7; Het, n = 6; *p < 0.05). (c) Luciferase reporter assay of Drd2-3′UTR containing a miR-124 target 
sequence. A miR-124 expression plasmid was transfected into HEK293 cells with reporter plasmids containing 
Drd2-3′UTR or Drd2-3′UTRmut (n = 3 per group). After transfection, the cells were incubated for 48 h and the 
luminescence signal was measured. (d) A schematic of AAV construct expressing shRNA for Drd2 and AcGFP 
(AAV-shDrd2). AAV-shDrd2 was injected into the 2 M miR-124-1+/− PFC. GFP-positive cells were observed 
in the PFC. L, lateral; M, medial; D, dorsal; V, ventral. PL, prelimbic, IL, infralimbic. (e,f) Drd2 knockdown 
partially rescued PPI deficit in the miR-124-1+/− mice. Startle response amplitude (e) and PPI (f) of AAV-
shDrd2-injected mice were analyzed (shControl, n = 8; shDrd2, n = 9; *p < 0.05; n.s., not significant). (g) A 
schematic of AAV construct expressing Drd2 (AAV-Drd2) or EGFP (AAV-GFP). AAV-Drd2 and -GFP were 
coinjected into the WT PFC. (h,i) Drd2 overexpression in the PFC causes PPI deficit similar to that observed 
in miR-124-1+/− mice. Startle response amplitude (h) and PPI (i) of AAV-Drd2-injected mice were analyzed. 
(Control, n = 6; Drd2, n = 7; *p < 0.05; n.s., not significant). Error bars in (b,c) represent ± SD. Box–whisker 
plots present median (center line), ±1.5 interquartile range (box) and minimal and maximal values (whiskers) 
in (e,f,h,i).
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identified 682 genes containing predicted miR-124 binding sites in their 3′UTR using TargetScan (http://www.
targetscan.org)32. We identified 3,114 genes with expected function in neurons using gene ontology terms. We 
identified 31 genes that overlap in these three criteria (Fig. 5a). We selected several genes from these candidates 
and confirmed increased expression of them in the miR-124-1+/− PFC by qRT-PCR. Among them, we focused 
on Nr3c1 (a glucocorticoid receptor), which enhances Drd2 expression in the frontal cortex of Disc1 transgenic 
mice33. By qRT-PCR we confirmed that Nr3c1 expression is significantly up-regulated in the miR-124-1+/− PFC 
(Fig. 5b; unpaired t test: t(11) = 4.509, p = 0.0009). Nr3c1-3′UTR has two miR-124 target sites that are highly con-
served in vertebrates (Fig. 5c). To examine whether Nr3c1 is directly regulated by miR-124, we carried out a lucif-
erase assay using the Nr3c1-3′UTR constructs (Fig. 5d). Luciferase activity with the native Nr3c1-3′UTR sequence 
was significantly down-regulated by cotransfection with the miR-124 expression plasmid when compared to that 
with mutated Nr3c1-3′UTR (Nr3c1-3′UTRmut) (one-way ANOVA: F(3,8) = 0.7195, p = 0.0051). These results sug-
gest that Nr3c1 is directly regulated by miR-124 in the PFC. Drd2 is likely to be regulated indirectly in the PFC by 
miR-124 through regulation of Nr3c1 expression change.
Several studies reported that miR-124 plays roles in pathogenesis of psychiatric disorders including 
Alzheimer’s disease and frontotemporal dementia (FTD)28,34. In their studies, human brains with Alzheimer’s 
disease exhibited a slight decrease of miR-124 expression, and the FTD mouse model with an impairment of 
age-dependent sociability also exhibited miR-124 down-regulation in the PFC. The impaired sociability of the 
FTD mouse model was shown to be accompanied with up-regulation of AMPA receptor subunits (Gria2, 3 and 4) 
following miR-124 down-regulation. We examined expression of Gria2, 3 and 4 in the 2 M miR-124-1+/− PFC by 
qRT-PCR, however, the expression of these genes was not significantly altered (Supplementary Material Fig. S2a; 
unpaired t test: t(11) = 1.461, p = 0.1720; unpaired t test: t(11) = 0.9990, p = 0.3393; unpaired t test: t(11) = 0.5248, 
p = 0.6101). A recent study reported that mice exposed to chronic ultra-mild stress exhibited depression-like 
behaviors and decreased miR-124 expression in the hippocampus (approximately 80% of non-stressed control 
mice)35. The reduction of miR-124 expression in the hippocampus caused by chronic ultra-mild stress induced 
the up-regulation of Glycogen synthase kinase 3β (Gsk3b). We measured expression of miR-124 and Gsk3b in 
the 2 M miR-124-1+/− hippocampus by qRT-PCR. We observed a decrease of miR-124 (approximately 73% of 
WT control mice, Supplementary Material Fig. S2b; unpaired t test: t(4) = 3.805, p = 0.0190) but no significant 
change of Gsk3b in the miR-124-1+/− hippocampus was detected (Supplementary Material Fig. S2c; unpaired t 
test: t(4) = 0.8932, p = 0.4222). Another study showed that small GTPase regulatory gene EPAC-deficient mice, 
which exhibit an impairment of learning and social interaction, displayed an elevation of miR-124 expression 
in the cortex and hippocampus, leading to down-regulation of miR-124 target gene Zif268 (Egr1)36. We did not 
observe a significant expression change of Zif268 in the 2 M miR-124-1+/− PFC and hippocampus by qRT-PCR 
analysis (Supplementary Material Fig. S2d; unpaired t test: t(11) = 1.631, p = 0.1312; unpaired t test: t(4) = 0.5992, 
Figure 5. Identification of Nr3c1 as an in vivo target gene of miR-124. (a) Venn diagram indicating up-regulated 
genes in the miR-124-1+/− PFC (blue circle), predicted miR-124 target genes (yellow circle), and neuron-
associated genes classified by ontology analysis (pink circle). miR-124 target genes were identified by TragetScan 
(cumulative weighted context++ score > −0.25). A list of the 31 genes at the intersection of the Venn diagram. 
(b) Nr3c1 expression increased in the miR-124-1+/− PFC. The Nr3c1 expression level was measured by qRT-PCR 
(WT, n = 7; Het, n = 6; ***p < 0.001). (c) A schematic showing a predicted miR-124 target gene Nr3c1. Predicted 
target sites are conserved in vertebrates. Two miR-124 target sequences are shown in red. (d) Luciferase reporter 
assays of Nr3c1-3′UTR. HEK293 cells were transfected with reporter plasmids of Nr3c1-3′UTR or Nr3c1-
3′UTRmut with the miR-124 expression plasmid. (n = 3 per group; *p < 0.05, **p < 0.01). Error bars in (b,d) 
represent ± SD.
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p = 0.5813). Thus, the expression levels of the previously reported miR-124 target genes, Gria2, Gria3, Gria4, 
Gsk3b, and Zif268, in the miR-124-1+/− PFC were not significantly affected compared to those in the control 
PFC. Since the experimental design of these studies is different from our study28,35,36, future studies are needed to 
elucidate the cause of varied outcomes.
Discussion
In the current study, several lines of evidence suggest that impaired sensorimotor gating in miR-124-1+/− mice is 
likely due to abnormal dopaminergic system by miR-124 reduction in the PFC. First, our whole-cell recordings 
from layer 5 pyramidal cells in the miR-124-1+/− PFC revealed that the amplitude of IPSCs significantly decreased 
by Drd2 agonist quinpirole application. Second, we found that Drd2 expression is upregulated in the miR-124-1+/− 
PFC. Third, injection of AAV-shDrd2 into the PFC of miR-124-1+/− mice partially rescued PPI impairment. 
Fourth, overexpression of Drd2 in the WT PFC by injection of AAV-Drd2 caused a PPI abnormality. In addition, 
a previous study reported that injection of dopamine receptor agonist apomorphine into the mouse PFC signifi-
cantly compromises PPI37. Accordingly, our results suggest the aberrant Drd2 pathway in the PFC is a major cause 
of sensorimotor gating deficit observed in miR-124-1+/− mice.
Several previous studies reported in vivo microRNA functions in normal brain using mouse mutants. In the 
striatum, miR-128 regulates motor behavior by modulating the ERK signaling network and neuronal excitabil-
ity38. miR-137, a schizophrenia risk gene product, controls synaptic plasticity and memory in the hippocampus39. 
miR-338-3p in the auditory thalamus regulates auditory thalamus development and acoustic-startle response40. 
In the current study, we showed that miR-124 is necessary for the normal brain function in the PFC. Whole-cell 
recordings from layer 5 pyramidal neurons in miR-124-1+/− PFC slices revealed that synaptic transmission into 
pyramidal neurons in the PFC is enhanced by miR-124-1 heterozygous deficiency. Previous studies showed the 
link between function of pyramidal neurons in the PFC and animal behavior. Loss of Dysbindin-1, whose genetic 
variation is associated with risk for schizophrenia, shows impairments in working memory, PPI, and higher 
locomotor activity. In the Dysbindin-1 mutant PFC, enhanced excitability of pyramidal neurons was observed41. 
DISC1 knockdown in the mouse PFC leads to deficits in PPI and methamphetamine-induced hyperactivity27. 
In DISC1 knockdown mice, attenuated electrophysiological responsiveness of pyramidal neurons in the PFC 
was observed. The mice lacking GluN2C, an NMDA receptor subunit, exhibited abnormalities in cognition and 
PPI as well as activity alteration of layer 5 pyramidal neurons in the PFC42. Since none of Dysbindin-1, DISC1 
and GluN2C transcripts contain the miR-124 target sequence, we speculate that these genes function in distinct 
pathways from that of miR-124 in normal brain function. We cannot rule out the possibility that the abnormal 
electrophysiological properties of pyramidal neurons in the miR-124-1+/− PFC are due to indirect effects from 
other cells. Future analysis using PFC pyramidal neuron specific-miR-124 conditional knock-out mice may clarify 
this point.
It was previously shown that Nr3c1 3′ UTR contains a miR-124 target sequence and that luciferase reporter 
expression was downregulated by miR-124 in a cultured cell system43. In the current study, we observed upregu-
lation of Nr3c1 by reduction of miR-124 in vivo, suggesting that Nr3c1 is an endogenous target of miR-124 in the 
prefrontal cortex. Blocking of Nr3c1 function decreases the Drd2 expression level, and affects the dopaminergic 
pathway in the frontal cortex of one mouse model of adolescent stress33. Conditional deletion of Nr3c1 in dopa-
minoceptive neurons affects the motivation of mice to self-administer cocaine44. These observations as well as on 
our luciferase reporter assay suggest that Drd2 is regulated indirectly in the PFC by miR-124 through modulation 
of Nr3c1 expression change. To examine this point in vivo, we performed injection of an Nr3c1 antagonist into 
the miR-124-1+/− PFC, however, we did not observe a statically significant change of PPI or an expression change 
of the Drd2 mRNA by RT-qPCR analysis using the whole PFC. It is possible that the Drd2 expression in the PFC 
is redundantly regulated by Nr3c1 and other molecules. There might be another possibility that only a subset of 
PFC neuronal cells is regulated by Nr3c1 and the expression change of Drd2 might be difficult to be detected in 
the whole PFC by RT-qPCR analysis.
Heterozygous deletions on human 8p23.1 containing miR-124-1 locus are associated with psychiatric disor-
ders15–18. Interestingly, a recent genome-wide association study reported that the inversion polymorphism in the 
8p23.1 region containing the human miR-124-1 locus is associated with neuroticism45. Further investigation of 
miR-124 mutations and/or expression levels in human neuropsychiatric disorder patients, including schizophre-
nia, Alzheimer’s disease, FTD, autism, and social impairment, may advance our understanding on the pathogen-
esis and/or exacerbation of these diseases.
Materials and Methods
Animal care. All recombinant mouse experiment procedures were approved by the Institutional Safety 
Committee on Recombinant DNA Experiments (approval ID 04220), Animal Experimental Committees of the 
Institute for Protein Research at Osaka University (approval ID 29-01-2), Committee on Animal Research at 
Kyoto University Graduate School of Medicine (approval ID MedKyo17071), and Experimental Animal Care 
Committee at National Institute for Physiological Sciences (approval ID 17A18). These procedures were per-
formed in compliance with the institutional guidelines. Mice were housed in a temperature-controlled room at 
22 °C with a 12 h light/dark cycle. Fresh water and rodent diet were available at all times.
Generation of miR-124-1+/− C57BL/6 N strain mice. We backcrossed miR-124-1+/− 129S6/SvEvTac 
mice46 with C57BL/6 N strain mice, using the speed congenic method (Central Institute for Experimental 
Animals, Japan)47, and generated miR-124-1+/− C57BL/6 N mice. We confirmed that over 99% of microsatellite 
DNA markers are from the C57BL/6 N genetic background.
1 0Scientific RepoRts |          (2019) 9:3445  | https://doi.org/10.1038/s41598-019-38910-2
www.nature.com/scientificreportswww.nature.com/scientificreports/
plasmid construction. The Drd2 3′ UTR or Nr3c1 3′ UTR fragment was amplified by PCR using 
KOD Plus (Toyobo), and cloned into pCR-Blunt vector (Invitrogen). The primer sequences are as fol-
lows: for Drd2 3′ UTR, forward, 5′-TGAGCTCGACCAGTGTTGGAGCTGAAGT TG-3′ and reverse, 
5′-TCTCGAGAGACCCCTCCAAGCTGCAGCTTC-3′; Nr3c1 3′ UTR, forward, 5′-CTTGCTAGCCTGCCTT 
ACTAAGAAAGGCTGCCTTAAAG-3′ and reverse, 5′-GAAGTCGACGAAAAACGAGCAAGCATAGTTC 
ACTG-3′. Mutations in the seed match region were introduced by PCR. The primer sequences are as follows: 
Drd2 3′ UTRmut, 5′-GCAAAGTGAGGAGGCTGTGGATGC-3′ and 5′-GAGGCACTGGCAGAGAAGA 
GACT-3′; Nr3c1 3′ UTRmut, 5′-CTTGCTAGCCT GCCTTACTAAGAAAGGCACGGAATTAGAAAGTTG-3′, 
5′-CACGGAATTATA GCTATTACTGTCTGG-3′, and 5′-AACTTCCCTTTTCTGATATACACGTGT-3′. 
The fragments of native and mutated Drd2 3′ UTR or Nr3c1 3′ UTR were ligated with pmirGLO vec-
tor (Promega) to generate pmirGLO-Drd2-3′UTR, pmirGLO-Drd2-3′UTRmut, pmirGLO-Nr3c1-3′UTR, 
and pmirGLO-Nr3c1-3′UTRmut. To generate AAV-DsRed or AAV-DsRed-miR-124 construct, the frag-
ment of CAG-DsRed or CAG-DsRed-miR-124-2 derived from RIP and RIP-miR-124-2 vectors (a gift 
from Tom Maniatis, Harvard University) was inserted into pAAV-IRES-hrGFP vector (Agilent technolo-
gies). For the production of AAV-shDrd2 and AAV-shControl, a target sequence for Drd2 (shDrd2)31 or 
shControl48 was subcloned into pBAsi-mU6 vector (Takara). The mU6-shControl or mU6-shDrd2 frag-
ment was inserted into the pAAV-CAG-AcGFP vector. For the production of AAV-Drd2, full-length 
cDNA fragment of mouse Drd2L (NCBI #NM_010077) was amplified by PCR using mouse brain cDNA. 
The primer sequences are 5′-GAATTCGCCACCATGGATCC ACTGAACCTGTCCTGGTAC-3′ and 
5′-TCTCGAGCTCAGCAGTGCAGGATCTTC ATGAAG-3′. The fragment was ligated with pAAV-CBh vector, 
in which the CBh promoter fragment49 was inserted into pAAV-CAG-mCherry50. To generate pAAV-EGFP, the 
EGFP fragment from pEGFP-N1 (Clontech) was cloned into pAAV-IRES-hrGFP vector (Agilent technologies).
Immunofluorescent staining of brain sections. For immunohistochemistry, 30-μm brain sections were 
washed twice in PBS, permeabilized with 0.1% Triton X-100 in PBS, and then incubated with PBS containing 4% 
donkey serum for 1 h for blocking. The samples were incubated with a primary antibody at 4 °C overnight. After 
PBS-washing, these samples were incubated with fluorescent-labeled secondary antibodies at room temperature 
for 2 h. The specimens were observed under a laser confocal microscope (LSM700, Carl Zeiss). Hoechst (Sigma) 
was used for nuclear staining. Primary antibodies are as follows: rat anti-GFP (Nacalai, 04404-26, 1:1000) and 
rabbit anti-DsRed (Clontech, 632496, 1: 1000) antibodies. We used Cy3-conjugated (Jackson ImmunoResearch 
Laboratories, 1:500) and Alexa Fluor 488-conjugated (Sigma, 1:500) secondary antibodies.
High-throughput mRNA sequencing (RNA-seq) analysis. Total RNAs from the mouse PFC were 
extracted using Trizol (Invitrogen). Library preparation was performed using 1 μg of total RNA and NEBNext 
Ultra Directional RNA Library Prep Kit for Illumina (New England Biolabs). RNA-seq was done with an Illumina 
HiSeq 1500 for 51 bp single-end. Approximately 40 M reads were obtained in each sample. The reads were mapped 
against mouse reference sequence. TIGAR2 was run with default settings. The expression level of each gene was 
quantified as FPKM (fragments per kilobase of exon per million mapped fragments).
qRT-PCR. Total RNA was extracted using Trizol reagent (Invitrogen), and reverse transcribed into cDNA 
using SuperScript II reverse transcriptase (Invitrogen) with random hexamers and Oligo dT (Invitrogen). 
Quantitative PCR was performed using a SYBR GreenER qPCR SuperMix Universal (Invitrogen) and Thermal 
Cycler Dice Real Time System Single MRQ TP870 (Takara) according to the manufacturer’s instructions. 
Quantification was carried out by Thermal Cycler Dice Real Time System software version 2.0 (Takara). Nucleotide 
sequences of primers are as follows: for Nr3c1, forward, 5′-CATTTGCCCTGGGTTGGAGATCA-3′ and reverse, 
5′-CATGCAGGGTAGAGT CATTCTCTG-3′; Rpl4, forward, 5′-GATATGCCATCTGTTCTGCCCT-3′ and 
reverse, 5′-CTTGCCAGCTCTCATTCTCTGA-3′. To quantify Drd2 expression level, we used the TaqMan probe 
(Applied Biosystems) and StepOnePlus Real-Time PCR System (Applied Biosystems). To detect mature miR-124, 
total RNA isolated using the Trizol reagent was reverse transcribed to cDNA using the TaqMan reverse transcrip-
tion reagent kit (Applied Biosystems) according to the manufacturer’s protocol. qRT-PCR was performed using 
TaqMan Universal PCR Master Mix (Applied Biosystems) and specific TaqMan mature-miRNA Assays for miR-
124 (Applied Biosystems).
Animal behavior assays. Locomotor activity. Spontaneous locomotor activity was measured as described 
previously51. Briefly, each mouse was placed at the center of open field box (W × D × H = 40 × 40 × 27 cm), and 
the total distance traveled and the time spent in the center area (W × D = 20 × 20 cm) were scored for 60 min 
using EthoVision software (Noldus). To examine methamphetamine-induced hyperactivity, mice received one 
intraperitoneal injection of methamphetamine (1 mg/kg) after 60 min of habituation in open field box.
Rotarod. Rotarod was performed as described previously51. Male mice were tested on an accelerating rotarod 
(4–50 rpm in 5 min per test), 3 tests a day (30-min break in-between), around the same time of the day over 3 
consecutive days, and the latency to fall was scored.
Elevated plus maze. Elevated plus maze was performed as described previously52. The plus maze consisted of a 
plus-shaped apparatus with two open and two closed arms, each with an open roof, elevated 40 cm from the floor. 
Male mice were put into center of the plus maze and its free movement was recorded for 10 min using EthoVision 
software.
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PPI. The startle response and PPI were measured using a startle reflex measurement system (SR-LAB) as pre-
viously described53 with minor modifications. The test session began by placing a male mouse in a plastic cyl-
inder and leaving it undisturbed for 30 min. The background white noise level in the chamber was 70 dB. A 
prepulse-pulse trial started with a 50-ms null period, followed by a 20-ms prepulse white noise (74, 78, 82, 86, or 
90 dB). After a 100-ms delay, the startle stimulus (40-ms, 120 dB white noise) was presented, followed by a 290-ms 
recording time. The total duration of each trial was 500 ms. A test session consisted of six trial types (pulse-only 
trial, and five types of prepulse-pulse trial). Six blocks of the six trial types were presented in a pseudorandomized 
order such that each trial type was presented once within a block. The formula 100 − ((Response on acoustic 
prepulse-pulse stimulus trials/Startle response on pulse-only trials) × 100) was used to calculate %PPI.
Forced swim test. Each mouse was placed in a transparent glass cylinder (8 cm in diameter × 20 cm high), con-
taining water at 22-23 °C to a depth of 15 cm, and forced to swim for 10 min. The duration of immobility was 
measured using digital counters with infrared sensors54.
Tail suspension test. Mice were suspended upside-down by the tail for 10 min. The session was recorded by a 
video camera and the duration of immobility was measured.
Social interaction. Social interaction was performed as described previously55. Two mice of identical genotypes 
previously housed in different cages, were placed into an open field together and allowed to explore freely for 
10 min. The behavior was recorded by a CCD camera and automatically analyzed by EthoVision software. The 
total duration of contacts, the number of contacts, and total distance traveled were measured. Contacts were 
defined as follows: if the nose of either of the two mice got close to the nose, body or hip of another mouse within 
2-3, 5.5–6.5, or 2-3 cm, respectively, the behavior was considered contact.
Y-maze. Y-maze was performed as described previously55. Each mouse was placed in the center of the symmetrical 
Y maze and was allowed to explore freely for 10 min. The sequence and total number of arms entered was recorded, 
using EthoVision software. The sequence triads, in which all three arms were represented (ABC, ACB, BAC, BCA, 
CAB, and CBA), were calculated as successful alternations to evaluate the normal cognition and working memory of 
the last arm entered. The percentage of spontaneous alternation is as follows. A number of triads containing entries 
into all three arms/maximum possible alternations (the total number of arms entered − 2) × 100.
slice preparation for electrophysiology. miR-124-1 heterozygote mice and their littermate control mice 
of either sex at postnatal 32–35 days were deeply anesthetized with isoflurane and sodium pentobarbital (50 mg/
kg, i.p.), and perfused transcardially with ice-cold normal artificial cerebrospinal fluid (ACSF) containing the 
following: 126 mM NaCl, 3 mM KCl, 1.3 mM MgSO4, 2.4 mM CaCl2, 1.2 mM NaH2PO4, 26 mM NaHCO3, and 
10 mM glucose, saturated with 95% O2 and 5% CO2. The brains were removed from the mice, and coronal slices 
(300-μm thick) were prepared from the PFC using a vibrating microslicer (VT1200S; Leica) and recovered in 
an interface chamber at 33 °C for 1 hour. The slices were then maintained in a submerged chamber at room 
temperature.
electrophysiology. Prefrontal cortical slices containing the prelimbic region were transferred into a 
submerged-type chamber perfused with normal ACSF. An infrared differential interference contrast video 
microscopy with an X40, 0.8NA water immersion lens (BX-50WI, Olympus) was used to visualize and target layer 
5 pyramidal neurons for whole-cell recordings. Patch pipettes (5–7 MΩ) were filled with a solution containing 
the following: 130 mM Cs-gluconate, 8 mM CsCl, 1 mM MgCl2, 0.6 mM EGTA, 10 mM HEPES, 3 mM MgATP, 
0.5 mM Na2GTP, 10 mM Na-phosphocreatine, and 0.2% biocytin (pH 7.3 adjusted with CsOH). The membrane 
potential of the recorded cells was held at the reversal potential of inhibitory postsynaptic currents (IPSCs, -70 
mV) or excitatory postsynaptic currents (EPSCs, 0 mV) for EPSC and IPSC recordings, respectively. We did not 
use series resistance compensation and selected cells with a series resistance < 25 MΩ for analysis. Electrical 
paired-pulse stimulation was applied at 0.2 Hz through a glass pipette placed in layer 2 just below layer 1, and 
whole-cell recordings were obtained using patch pipettes located 65 ± 9.0 μm (mean ± SEM) lateral to the stim-
ulating electrode. The interval of the paired-pulse stimulation was 50 and 100 ms for EPSC and IPSC recordings, 
respectively. To examine the relationship between stimulus intensity and response amplitude, we used stimulus 
currents that evoked the minimum (3–7 μA), intermediate, and maximum (10–140 μA) EPSC amplitudes. The 
current intensities used for evoking IPSCs were the same as those employed for evoking EPSCs in each cell. 
Quinpirole at 5 μM was added to the bath solution and the effect was assessed 10 min after the application. All 
of the whole-cell recordings were conducted using a Multiclamp 700B amplifier, and data were analyzed using 
pClamp9 software (Molecular Devices). After whole-cell recording, the slices were fixed with 4% paraformal-
dehyde in 0.1 M phosphate buffer (PB, pH 7.4) overnight. To visualize the recorded neurons, the slices were 
incubated with streptavidin conjugated to Alexa 488 (1:1000; Life Technologies) in 25 mM PBS containing 0.1% 
Triton X-100 overnight at room temperature. Images of slices were obtained using an A1R confocal microscope 
(Nikon) with a 40x objective.
AAV production. AAV was produced by triple transfection of an AAV vector plasmid, an adenovirus helper 
plasmid, and an AAV helper plasmid (pAAV2/9) into AAV-293 cells by the calcium phosphate method. The cells 
were harvested at 72 h after transfection, and lysed by four freeze-and-thaw cycles. The supernatant was collected 
by centrifugation, and treated with benzonase nuclease (Novagen) for 10 min at 45 °C to eliminate cellular DNA/
RNA and excess plasmid DNAs. The viruses were purified by iodixanol step gradient. The gradient was formed 
in Ultra-Clear centrifuge tubes (14 × 95 mm, Beckman) by first adding 1.59 ml of 54% iodixanol (Axis-Shield) in 
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PBS-MK buffer (1 × PBS, 1 mM MgCl2, and 25 mM KCl) and then overlaying 1.59 ml of 40% iodixanol in PBS-MK 
buffer, 2.12 ml of 25% iodixanol in PBS-MK buffer containing phenol red, and 3.18 ml of 15% iodixanol in PBS-MK 
buffer containing 1 M NaCl. Finally, the lysate was applied on top of the gradient. The tubes centrifuged for 3 h 
at 40,000 rpm at 18 °C in a SW40Ti rotor. The 54–40% fraction containing virus was collected using an 18-gauge 
needle. The fraction was concentrated using an Amicon Ultra Centrifugal Filter Ultracel-100 K (Millipore). 
A titer of each AAV (in vector genomes (VG)/mL) was determined by qPCR using SYBR Green ER Q-PCR 
Super Mix (Invitrogen) and Thermal Cycler Dice Real Time System Single MRQ TP870 (Takara). The primers 
used for AAV titrations are as follows: for DsRed, forward, 5′-ACAAGGTGAAGTTCATCGGCGTGA-3′ and 
reverse, 5′-AGCTTGGCG TCCACGTAGTAGTAG-3′; EGFP, forward, 5′-GAAGGGCATCGACTTCAAGGAG 
GA-3′ and reverse, 5′-CTTGATGCCGTTCTTCTGCTTGTC-3′; CBh promoter, forward, 5′-TCCATTGACGTC 
AATGGGTGGAGT-3′ and reverse, 5′-CATTGACG TCAATAGGGGGCGTAC-3′.
Stereotaxic viral injection. AAVs were injected into the PFC of WT and/or miR-124-1+/− mice (for PFC, 
+1.69 mm posterior to the bregma, 0.3 mm lateral from the midline, −1.5 mm depth from the dura). The PPI of 
injected mice were measured 2 wks after the injection. Coronal sections of the PFC were prepared and immunos-
tained with an anti-GFP or anti-DsRed antibody, followed by the Alexa Fluor 488-conjugated or Cy3-conjugated 
secondary antibody. Immunofluorescence was detected with a laser confocal microscope (LSM700, Carl Zeiss).
Luciferase reporter assay. We transfected 0.1 μg of the luciferase reporter vectors (Drd2-3′UTR, 
Drd2-3′UTRmut, Nr3c1-3′UTR, or Nr3c1-3′UTRmut) and 1.1 μg of the miR-124 expression vector 
(pBAsi-mU6-shControl or pBAsi-mU6-pre-miR-124-1)2 into HEK293 cells in a 12-well plate using the calcium 
phosphate method. A β-galactosidase expression vector (β-SV; Promega) was cotransfected for normalization of 
transfection efficiency. After transfection, the cells were incubated for 48 h and lysed with Reporter Lysis Buffer 
(Promega). The luminescence signal was detected using a GloMax Multi+ detection system (Promega).
electroretinogram recordings. The method of recording the electroretinograms (ERGs) was performed 
as described previously with some modifications56. In brief, mice were dark adapted for more than 4 h, and then 
anesthetized with an intraperitoneal injection of 100 mg/kg ketamine and 10 mg/kg xylazine. ERG responses 
were measured using the PuREC system with LED LS-100 (Mayo Corporation). After mice were light adapted for 
10 min, the photopic ERGs were recorded on a rod-suppressing white background of 1.3 log cd sm−2. Four levels 
of stimulus intensities ranging from −0.5 to 1 log cd sm−2 were used for the photopic ERG recordings. Sixteen 
responses were averaged for photopic recordings.
statistical analysis. Statistical analyses were performed using GraphPad Prism version 6.04 (GraphPad 
Software). Single comparisons were performed using paired or unpaired Student’s t test, and multiple compar-
isons were performed using one-way ANOVA with post hoc Tukey–Kramer test. The statistical significance of 
experiments involving three or more groups and two or more treatments was assessed by two-way ANOVA 
with post hoc Tukey–Kramer or Bonferroni’s test. Data are reported as median (center line), ±1.5 interquartile 
range (box), minimal and maximal values (whiskers), as mean ± SEM or as mean ± SD. The analyzed number of 
samples is indicated in the figure legends. Asterisks indicate significance values as follows: *p < 0.05, **p < 0.01, 
***p < 0.001 and ****p < 0.0001.
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